-- True Family Commonality. Key components, including reagents, can be
shared across ARCHITECT instruments and multiple testing sites for
effective and efficient patient care.
-- Enhanced Assay and System Dynamics. ARCHITECT instruments offer
advanced technology, which means laboratories, physicians and,
ultimately, patients can be confident in the accuracy of test results.
-- Integration without Compromise. The ARCHITECT family combines
immunoassay and clinical chemistry technologies without jeopardizing
key performance, including turnaround time or accuracy of results.
Abbott recently introduced three other instruments in the ARCHITECT family: the ARCHITECT c16000(TM) clinical chemistry analyzer, the ARCHITECT ci16200, an integrated immunoassay and clinical chemistry analyzer, and the ARCHITECT i4000SR(TM) analyzer for high volume immunoassay testing.
About Abbott Diagnostics
Abbott Diagnostics is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, blood banks, physician offices and clinics. With more than 69,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnostics from an art to a science through the company's commitment to improving patient care and lowering overall costs. The history of Abbott Diagnostics is filled with examples of first-of-a-kind products and significant technological advancements.
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
Copyright©2008 PR Newswire.
All rights reserved